A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)

Clinical trial NCT05817669 · COMPLETED

Trial details

NCT number: NCT05817669
Sponsor: argenx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sjögren's Syndrome

Start date: 2023-04-04
Primary completion: 2024-01-29
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.